Blend Labs (BLND) Projected to Post Quarterly Earnings on Thursday

Blend Labs (NYSE:BLND) is projected to issue its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect the company to announce earnings of $0.02 per share and revenue of $32.7960 million for the quarter. Blend Labs has set its Q3 2025 guidance at EPS.Parties can check the company’s upcoming Q3 2025 earningsummary page for the latest details on the call scheduled for Thursday, November 6, 2025 at 4:30 PM ET.

Blend Labs (NYSE:BLND) last issued its earnings results on Thursday, August 7th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.05). The firm had revenue of $31.52 million for the quarter, compared to the consensus estimate of $31.93 million. On average, analysts expect Blend Labs to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Blend Labs Trading Down 2.3%

Shares of NYSE BLND opened at $3.24 on Tuesday. The firm has a market capitalization of $840.01 million, a PE ratio of -21.57 and a beta of 1.24. Blend Labs has a 1 year low of $2.63 and a 1 year high of $5.53. The firm’s 50-day moving average is $3.64 and its 200-day moving average is $3.49.

Insider Buying and Selling

In other Blend Labs news, insider Nima Ghamsari sold 311,886 shares of Blend Labs stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $2.90, for a total value of $904,469.40. Following the transaction, the insider owned 5,754,051 shares of the company’s stock, valued at approximately $16,686,747.90. The trade was a 5.14% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Brian Kneafsey sold 25,000 shares of Blend Labs stock in a transaction that occurred on Wednesday, October 15th. The shares were sold at an average price of $3.34, for a total transaction of $83,500.00. Following the completion of the transaction, the insider directly owned 687,909 shares in the company, valued at approximately $2,297,616.06. The trade was a 3.51% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 361,886 shares of company stock worth $1,059,719. Insiders own 35.52% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the stock. Captrust Financial Advisors bought a new position in Blend Labs in the second quarter valued at approximately $35,000. Cerity Partners LLC lifted its stake in Blend Labs by 58.8% in the second quarter. Cerity Partners LLC now owns 29,345 shares of the company’s stock valued at $97,000 after buying an additional 10,862 shares in the last quarter. Jump Financial LLC bought a new position in Blend Labs in the second quarter valued at approximately $38,000. State of Wyoming lifted its stake in Blend Labs by 61.0% in the second quarter. State of Wyoming now owns 31,962 shares of the company’s stock valued at $105,000 after buying an additional 12,115 shares in the last quarter. Finally, Creative Planning raised its holdings in shares of Blend Labs by 81.4% in the second quarter. Creative Planning now owns 34,036 shares of the company’s stock valued at $112,000 after purchasing an additional 15,276 shares during the last quarter. Institutional investors own 52.56% of the company’s stock.

Analysts Set New Price Targets

BLND has been the topic of several recent research reports. Keefe, Bruyette & Woods reduced their target price on shares of Blend Labs from $4.00 to $3.75 and set a “market perform” rating on the stock in a research note on Friday, August 8th. UBS Group reduced their target price on shares of Blend Labs from $4.00 to $3.50 and set a “neutral” rating on the stock in a research note on Friday, August 8th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Blend Labs in a research report on Wednesday, October 8th. Wall Street Zen upgraded shares of Blend Labs from a “sell” rating to a “hold” rating in a research report on Sunday, August 17th. Finally, Canaccord Genuity Group reiterated a “buy” rating and issued a $5.25 price target on shares of Blend Labs in a research report on Tuesday, October 28th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $4.88.

About Blend Labs

Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.